Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 2-3
109
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Single-nucleotide Polymorphism rs17860041 A/C in the Promoter of the PPIA Gene is Associated with Susceptibility to Kawasaki Disease in Chinese Children

, , , , , , , & show all

References

  • An P, Wang LH, Hutcheson-Dilks H. 2007. Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog. 3(6):e88.
  • Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K. 2005. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 47(2):232–34.
  • Chen YT, Liao WL, Lin YJ, Chen SY, Tsai FJ. 2014. Association between SRC-1 gene polymorphisms and coronary artery aneurysms formation in Taiwanese children with Kawasaki disease. J Clin Lab Anal. 28(6):435–39.
  • Cheung YF, Karmin O, Woo CW, Armstrong S, Siow YL, Chow PC, Cheung EW. 2008. Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr. 8(8):20.
  • Cho JH, Han MY, Cha SH, Jung JH, Yoon KL. 2014. Genetic polymorphism of SMAD5 is associated with Kawasaki disease. Pediatr Cardiol. 35(4):601–07.
  • Haendler B, Hofer E. 1990. Characterization of the human cyclophilin gene and of related processed pseudogenes. Eur J Biochem. 190(3):477–82.
  • Hsieh KS, Lai TJ, Hwang YT, Lin MW, Weng KP, Chiu YT, Ho TY, Chen CS, Shiue YL, Hsiao M, et al. 2011. IL-10 promoter genetic polymorphisms and risk of Kawasaki disease in Taiwan. Dis Markers. 30(1):51–59.
  • Hui-Yuen JS, Duong TT, Yeung RS. 2006. TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol. 176(10):6294–301.
  • Japanese Circulation Society Joint Research Group. 2005. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J. 47(6):711–32.
  • Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC. 2000. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res. 87(9):789–96.
  • Katayama K, Matsubara T, Fujiwara M, Koga M, Furukawa S. 2000. CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol. 121(3):566–70.
  • Kawasaki T. 1967. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Jpn J Allergol. 16(3):178–222.
  • Kim KY, Kim DS. 2016. Recent advances in Kawasaki disease. Yonsei Med J. 57(1):15–21.
  • Kimio S, Patrizia N, Berk BC. 2010. Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal. 12(5):675–82.
  • Kuo HC, Liang CD, Yu HR, Wang CL, Lin IC, Liu CA, Chang JC, Lee CP, Chang WC, Yang KD. 2011. CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease. J Clin Immunol. 31(2):240–44.
  • Lamas S. 2005. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors. Kidney Int. 68(2):898–907.
  • Li S, Shi R, Tian L, Chen J, Li X, Huang L, Yang Z. 2019. The Relationship of COX-2 gene polymorphisms and susceptibility to Kawasaki disease in Chinese population. Immunol Invest. 48(2):181–89.
  • Li Z, Han D, Jiang J, Chen J, Tian L, Yang Z. 2017. Association of PECAM-1 gene polymorphisms with Kawasaki disease in Chinese children. Dis Markers. 2017:2960502.
  • Lu Y, Liu R, Zha L, Yuan S, Tian L, Chen J, Huang L, Yang Z. 2018. Association of thrombomodulin gene C1418T polymorphism with susceptibility to Kawasaki disease in Chinese children. Dis Markers. 2018:1064380.
  • Madlala P, Singh R, An P, Werner L, Mlisana K, Abdool Karim SS, Winkler CA, Ndung’u T. 2016. Association of polymorphisms in the regulatory region of the cyclophilin A gene (PPIA) with gene expression and HIV/AIDS disease progression. J Acquir Immune Defic Syndr. 72(5):465–73.
  • Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, et al. 1986. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 315(6):341–47.
  • Nigro P, Satoh K, O’Dell MR. 2011. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 208(1):53–66.
  • Onouchi Y. 2012. Genetics of Kawasaki disease: what we know and don’t know. Circ J. 76(7):1581–86.
  • Palacin M, Rodriguez I, Garcia-Castro M, Ortega F, Reguero JR, López‐Larrea C, Morís C, Alvarez V, Coto E. 2008. A search for cyclophilin-A gene (PPIA) variation and its contribution to the risk of atherosclerosis and myocardial infarction. Int J Immunogenet. 35(2):159–64.
  • Ramachandran S, Venugopal A, Kutty VR, AV GD, Chitrasree V, Mullassari A, Pratapchandran NS, Santosh KR, Pillai MR, Kartha CC. 2014. Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease. Cardiovasc Diabetol. 13(7):38.
  • Schmid FX. 1995. Protein folding. Prolyl isomerases join the fold. Curr Biol. 5(9):993–94.
  • Shulman ST, Rowley AH. 2015. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 11(8):475–82.
  • Straface E, Gambardella L, Metere A, Marchesi A, Palumbo G, Cortis E, Villani A, Pietraforte D, Viora M, Malorni W, et al. 2010. Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease. Biochem Biophys Res Commun. 392(3):426–30.
  • Sun W, Xu Y, Xin Q, Zhang Y, Cui B, Hong F. 2019. Association between polymorphism in cyclophilin a gene and its serum and placental expression in Han Chinese women with severe preeclampsia. Pregnancy Hypertens. 15:84–92.
  • Takahashi K, Oharaseki T, Yokouchi Y. 2011. Pathogenesis of Kawasaki disease. Clin Exp Immunol. 164(Suppl 1):20–22.
  • Takatsuki S, Ito Y, Takeuchi D, Hoshida H, Nakayama T, Matsuura H, Saji T. 2009. IVIG reduced vascular oxidative stress in patients with Kawasaki disease. Circ J. 73(7):1315–18.
  • Tseng WN, Lo MH, Guo MM, Hsieh KS, Chang WC, Kuo HC. 2014. IL-31 associated with coronary artery lesion formation in Kawasaki disease. PLoS One. 9(8):e105195.
  • Vinitha A, Kutty VR, Vivekanand A, Reshmi G, Divya G, Sumi S, Santosh KR, Pratapachandran NS, Ajit MS, Kartha CC, et al. 2016. PPIA rs6850: A > G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease. Mol Cell Biochem. 412(1–2):259–68.
  • Weng KP, Hsieh KS, Hwang YT, Huang SH, Lai TJ, Yuh YS, Hou YY, Lin CC, Huang SC, Chang CK, et al. 2010. IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease. Circ J. 74(5):983–89.
  • Yim D, Curtis N, Cheung M, Burgner D. 2013. Update on Kawasaki disease: epidemiology, aetiology and pathogenesis. J Paediatr Child Health. 49(9):704–08.
  • Yoshimura K, Tatsumi K, Iharada A, Tsuji S, Tateiwa A, Teraguchi M, Ogino H, Kaneko K. 2009. Increased nitric oxide production by neutrophils in early stage of Kawasaki disease. Eur J Pediatr. 168(9):1037–41.
  • Zha L, Li S, Liu X, Li Z, Jiang J, Huang L, Yang Z. 2019. Association of miR-146a gene polymorphism at loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C with susceptibility to Kawasaki disease in Chinese children. Pediatr Cardiol. 40(3):504–12.
  • Zhu FH, Ang JY. 2016. The clinical diagnosis and management of Kawasaki disease: a review and update. Curr Infect Dis Rep. 18(10):32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.